Tevogen Bio Holdings Inc.

NASDAQ (USD): Tevogen Bio Holdings Inc. (TVGN)

Last Price

1.16

Today's Change

-0.04 (3.33%)

Day's Change

1.14 - 1.20

Trading Volume

396,870

Overview

Market Cap

213 Million

Shares Outstanding

183 Million

Avg Volume

971,635

Avg Price (50 Days)

1.15

Avg Price (200 Days)

1.17

PE Ratio

-5.27

EPS

-0.22

Earnings Announcement

04-Aug-2025

Previous Close

1.20

Open

1.14

Day's Range

1.14 - 1.2

Year Range

0.256 - 3.09

Trading Volume

432,519

Price Change Highlight

1 Day Change

-3.33%

5 Day Change

-4.92%

1 Month Change

-11.45%

3 Month Change

1.75%

6 Month Change

14.85%

Ytd Change

9.43%

1 Year Change

48.99%

3 Year Change

-88.43%

5 Year Change

-88.33%

10 Year Change

-88.33%

Max Change

-88.33%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment